{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:01:51Z","timestamp":1761102111773},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"BC Children's Hospital Foundation"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ymgme.2014.07.004","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T21:17:49Z","timestamp":1405459069000},"page":"226-232","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Health economic evaluation of plasma oxysterol screening in the diagnosis of Niemann\u2013Pick Type C disease among intellectually disabled using discrete event simulation"],"prefix":"10.1016","volume":"114","author":[{"given":"Clara D.M.","family":"van Karnebeek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tima","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Sirrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.07.004_bb0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","article-title":"Recommendations on the diagnosis and management of Niemann\u2013Pick disease type C","volume":"98","author":"Wraith","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"NP-C Guidelines Working Group: recommendations for the diagnosis and management of Niemann\u2013Pick disease type C: an update","volume":"106","author":"Patterson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann\u2013Pick disease type C: long-term data from a clinical trial","volume":"99","author":"Wraith","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","article-title":"Miglustat in patients with Niemann\u2013Pick disease Type C (NP-C): a multicenter observational retrospective cohort study","volume":"98","author":"Pineda","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-term miglustat therapy in children with Niemann\u2013Pick disease type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10545-006-0384-7","article-title":"The natural history of Niemann\u2013Pick disease type C in the UK","volume":"30","author":"Imrie","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-med-042711-140053","article-title":"Genetic basis of intellectual disability","volume":"64","author":"Ellison","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awl260","article-title":"The adult form of Niemann\u2013Pick disease type C","volume":"130","author":"S\u00e9vin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann\u2013Pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1388-1981(00)00158-X","article-title":"Niemann\u2013Pick type C: a disorder of cellular cholesterol trafficking","volume":"1529","author":"Ory","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0060","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1194\/jlr.D015735","article-title":"A sensitive and specific LC\u2013MS\/MS method for rapid diagnosis of Niemann\u2013Pick C1 disease from human plasma","volume":"52","author":"Jiang","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0065","first-page":"35","article-title":"Fischer","volume":"8","author":"Stampfer","year":"2013","journal-title":"H. Runz. Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J. Rare Dis."},{"issue":"21","key":"10.1016\/j.ymgme.2014.07.004_bb0070","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1093\/hmg\/ddt284","article-title":"Genetic screening for Niemann\u2013Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study","volume":"22","author":"Bauer","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2014.07.004_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2014.01.011","article-title":"The Metabolic Evaluation of the Child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource","volume":"111","author":"van Karnebeek","year":"2014","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-7-47","article-title":"The treatable intellectual disability APP www.treatable-id.org: a digital tool to enhance diagnosis & care for rare diseases","volume":"7","author":"Van Karnebeek","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/WNL.0b013e3182345896","article-title":"Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"77","author":"Michelson","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0090","first-page":"S165","article-title":"Systematic evaluation of patients with global developmental delay\/intellectual disability for treatable inborn errors of metabolism: first clinical study results","volume":"35","author":"Van Karnebeek","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00019053-200523040-00003","article-title":"Pharmacoeconomic analyses using discrete event simulation","volume":"23","author":"Caro","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1352\/0895-8017(2005)110[253:EOMRIC]2.0.CO;2","article-title":"Etiology of mental retardation in children referred to a tertiary care center: a prospective study","volume":"110","author":"Van Karnebeek","year":"2005","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0105","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1212\/WNL.0b013e3182563b82","article-title":"Development of a suspicion index to aid diagnosis of Niemann\u2013Pick disease type C","volume":"78","author":"Wijburg","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0110","unstructured":"Medical Services Plan physician payment schedule [http:\/\/www.health.gov.bc.ca\/msp\/infoprac\/physbilling\/payschedule\/index.html]."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0115","series-title":"Product monograph: miglustat (Zavesca)","author":"Actelion Pharmaceuticals Ltd.","year":"2012"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3111\/13696990903245863","article-title":"Cost of illness associated with Niemann\u2013Pick disease type C in the UK","volume":"12","author":"Imrie","year":"2009","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/13668250.2011.648609","article-title":"How much does intellectual disability really cost? First estimates for Australia","volume":"37","author":"Doran","year":"2012","journal-title":"J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0130","unstructured":"Purchasing power parities statistics [http:\/\/stats.oecd.org\/Index.aspx?DataSetCode=CPL]."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0135","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16390","article-title":"The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders","volume":"16","author":"Wyatt","year":"2012","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/ldr049","article-title":"Mapping for economic evaluation","volume":"101","author":"Chuang","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0150","series-title":"Diagnostic and Prognostic Research In Paediatrics: Children With Meningeal Signs","author":"Oostenbrink","year":"2001"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1750-1172-7-76","article-title":"Dysphagia as a risk factor for mortality in Niemann\u2013Pick disease type C: systematic literature review and evidence from studies with miglustat","volume":"7","author":"Walterfang","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ymgme.2009.11.007","article-title":"Clinical experience with miglustat therapy in pediatric patients with Niemann\u2013Pick disease type C; a case series","volume":"99","author":"Pineda","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","article-title":"Niemann\u2013Pick disease type C","volume":"64","author":"Vanier","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0185","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ajmg.a.31735","article-title":"The National Niemann\u2013Pick C1 disease database: report of clinical features and health problems","volume":"143A","author":"Garver","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2014.07.004_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in 2 patients with Niemann\u2013Pick type C disease","volume":"108","author":"Matsuo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/138920111795542697","article-title":"New agents and approaches to treatment in Niemann\u2013Pick type C disease","volume":"12","author":"Perez-Poyato","year":"2011","journal-title":"Curr Pharm Biotechnol."},{"key":"10.1016\/j.ymgme.2014.07.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.R047837","article-title":"Disease and mobilization of lysosomal cholesterol by cyclodextrin","author":"Vance","year":"2014","journal-title":"J. Lipid Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921400208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921400208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T07:40:27Z","timestamp":1717054827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921400208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S109671921400208X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health economic evaluation of plasma oxysterol screening in the diagnosis of Niemann\u2013Pick Type C disease among intellectually disabled using discrete event simulation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}